China CAS NO 260273-82-3 Factory

Our growth depends to the superior products ,great talents and repeatedly strengthened technology forces for CAS NO 260273-82-3,260273-82-3,Paliperidone intermediate,Paliperidone advance intermediate,3-(2-Chloroethyl)-2-methyl-9-hydroxy-4H, Our firm quickly grew in size and reputation because of its absolute dedication to superior quality manufacturing, substantial price of solutions and fantastic customer services.
CAS NO 260273-82-3, We have now a dedicated and aggressive sales team, and many branches, catering to our main customers. We have been looking for long-term business partnerships, and ensure our suppliers that they will surely benefit in both short and long run.

Hot Products

  • Ethyl Isocyanatoacetate

    Ethyl Isocyanatoacetate

    Product Name:Ethyl Isocyanatoacetate
    Molecular Formula:C5H7NO3
    Molecular Weight:129.11
    CAS Registry Number:2949-22-6
  • 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile

    1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile

    Product Name:1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile
    Molecular Formula:C14H9FN4
    Molecular Weight:252.25
    CAS Registry Number:256376-65-5
  • Oxytocin

    Oxytocin

    Product Name:Oxytocin
    Molecular Formula:C43H66N12O12S2
    Molecular Weight;1007.19
    CAS Registry Number;50-56-6
  • Relebactam

    Relebactam

    Product Name:Relebactam
    Molecular Formula:C12H20N4O6S
    Molecular Weight;348.38
    CAS Registry Number;1174018-99-5
  • Cefepime hydrochloride

    Cefepime hydrochloride

    Product Name:Cefepime hydrochloride
    Molecular Formula:C19H28Cl2N6O6S2
    Molecular Weight;571.49
    CAS Registry Number;123171-59-5
  • (2R,3S)-3-Phenylisoserine hydrochloride

    (2R,3S)-3-Phenylisoserine hydrochloride

    Product Name:(2R,3S)-3-Phenylisoserine hydrochloride
    Molecular Formula:C9H12ClNO3
    Molecular Weight:217.65
    CAS Registry Number:132201-32-2

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept